General Information
Revision date
2006-11-20
Product name
Phenergan Injection
Product Synonyms
Promethazine HCl Injection, Promethazine Hydrochloride
CAS No.
58-33-3
supplier name
Wyeth
Icons in SDS
Company Information
company name
Wyeth
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview This contains an active pharmaceutical ingredient that can affect body functions; handle with caution. Appearance Biopharmaceutical liquid Physical State Liquid Odor Not available Potential Physical Hazards None known
Potential health effects
Eyes Not available Skin Not available Inhalation Not available Ingestion The most common effects may include severe drowsiness, sedation, dryness of mouth, nose, or throat, blurred vision, dizziness, confusion, disorientation, extrapyramidal symptoms, lassitude, tinnitus, incoordination, flushing or redness of face, shortness of breath, fatigue, euphoria, nervousness, diplopia, insomnia, tremors, convulsive seizures, excitation, catatonic- like states, hysteria, severe hypotension, and hallucinations. May impair ability when driving a motor vehicle or operating machinery. May cause harm to the unborn child. Please see Patient Package Insert for further information. Therapeutic Target Organ(s) Central nervous system. Not listed by OSHA, NTP or IARC.
Environmental effects
There is no known ecological information for this product.
